Not applicableUnknownNCT05821790What this trial is testingRole of the Tumor Microenvironment in Aggressive MeningiomasWho this might be right forMeningioma Assistance Publique - Hôpitaux de Paris 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02407405What this trial is testingMEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform NeurofibromasWho this might be right forNeurofibromatosis 1 (NF1)Plexiform Neurofibromas (PN) National Cancer Institute (NCI) 36
Not applicableActive Not RecruitingNCT04759781What this trial is testingMElanoma Research Lymph Node Prediction Implementation National_001Who this might be right forMelanoma SkylineDx 1,820
Not applicableStudy completedNCT02246231What this trial is testingEffect of Implant Position on Magnetic Resonance Image DistortionWho this might be right forNeurofibromatosis Type 2 Manchester University NHS Foundation Trust 5
Testing effectiveness (Phase 2)Study completedNCT02352844What this trial is testingEverolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 MutationsWho this might be right forSolid MalignancySolid Tumor Washington University School of Medicine 12
Testing effectiveness (Phase 2)Ended earlyNCT01345136What this trial is testingStudy of RAD001 for Treatment of NF2-related Vestibular SchwannomaWho this might be right forNeurofibromatosis Type 2Neuroma, Acoustic Jonsson Comprehensive Cancer Center 4
Not applicableLooking for participantsNCT00598351What this trial is testingNatural History Study of Patients With Neurofibromatosis Type 2Who this might be right forNeurofibromatosis National Institute of Neurological Disorders and Stroke (NINDS) 269
Testing effectiveness (Phase 2)Looking for participantsNCT05180825What this trial is testingPediatric Low Grade Glioma - MEKinhibitor TRIal vs ChemotherapyWho this might be right forGrade 1 GliomaMixed Glio-neuronal TumorsPleomorphic Xanthoastrocytoma University Hospital, Strasbourg, France 134
Testing effectiveness (Phase 2)Study completedNCT03231306What this trial is testingPhase II Study of Binimetinib in Children and Adults With NF1 Plexiform NeurofibromasWho this might be right forNeurofibromatosis Type 1Plexiform Neurofibroma University of Alabama at Birmingham 45
Testing effectiveness (Phase 2)Ended earlyNCT00326872What this trial is testingAZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the SpineWho this might be right forNeurofibromatosis Type 1Plexiform NeurofibromaSpinal Cord Neurofibroma National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Study completedNCT01673009What this trial is testingPhase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform NeurofibromasWho this might be right forNeurofibromatosis Indiana University 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT05309668What this trial is testingPharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PNWho this might be right forNeurofibromatosis Type 1 AstraZeneca 36
Not applicableStudy completedNCT02298270What this trial is testingResiliency Training for Patients With Neurofibromatosis Via Videoconferencing With SkypeWho this might be right forNeurofibromatosisNeurofibromatosis INeurofibromatosis 2+1 more Massachusetts General Hospital 65
Not applicableStudy completedNCT03406208What this trial is testingResiliency Training for Adults With Neurofibromatosis Via Live VideoconferencingWho this might be right forNeurofibromatosesNeurofibromatosis 1Neurofibromatosis 2+1 more Massachusetts General Hospital 228
Testing effectiveness (Phase 2)Ended earlyNCT02315625What this trial is testingStudy of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive SurgeryWho this might be right forNeuroendocrine TumorsNeuroendocrine CarcinomaNeuroendocrine Neoplasms+2 more National Cancer Institute (NCI) 16
Not applicableStudy completedNCT02435628What this trial is testingRelationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NFWho this might be right forNeurofibromatosis Massachusetts General Hospital 86
Testing effectiveness (Phase 2)Ended earlyNCT04544007What this trial is testingA Phase II Trial of Poly-ICLC for Low-Grade GliomasWho this might be right forNF1Low-grade Glioma University of Alabama at Birmingham 3
Testing effectiveness (Phase 2)Study completedNCT00589784What this trial is testingPhase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable MeningiomaWho this might be right forCNS CancerMeningiomaIntracranial Hemangiopericytoma+2 more Memorial Sloan Kettering Cancer Center 50
Early research (Phase 1)WithdrawnNCT01850225What this trial is testingFeasibility Study of Auditory Brainstem Implant in Young ChildrenWho this might be right forBilateral Cochlear AplasiaBilateral Cochlear Nerve DeficiencyBilateral Cochlear Ossification Secondary to Meningitis House Research Institute
Not applicableLooking for participantsNCT01885767What this trial is testingNeurofibromatosis (NF) Registry PortalWho this might be right forNeurofibromatosis 1Neurofibromatosis 2Schwannomatosis The Children's Tumor Foundation 20,000